Saltar al contenido
Dispositivos y mediciónRevisión de evidencia3 min read

AI on wearables for sleep disorders: 46 studies, mostly sleep apnea screening

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Wearable Artificial Intelligence for Sleep Disorders: Scoping Review. · Journal of medical Internet research · 2025 · Artículo original ↗

Idea principal

A scoping review of 46 studies found that wearable AI for sleep disorders was used mainly to screen and diagnose sleep apnea, with none testing it for treatment; 30 of 46 (65%) used commercial devices. It maps what exists and does not pool accuracy, so it cannot say how well any of these systems work.

Study design

Revisión de evidencia

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Sleep disorders affect 30%-45% of adults and are linked to diabetes and cardiovascular disease, but in-lab testing is expensive and impractical for long-term monitoring. The authors set out to map which AI-powered wearable devices have been studied for sleep disorders, what the studies look like, what the wearables measure, and which AI methods are used.

Población y método

Scoping review searching seven databases (MEDLINE, PsycINFO, Embase, IEEE Xplore, ACM Digital Library, Google Scholar and Scopus) for peer-reviewed work published before March 2024. Eligible studies used AI algorithms on wearable data to detect or predict sleep disorders. Two reviewers independently selected studies and extracted data, resolving disagreements by consensus, and results were synthesized narratively.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    The search found 615 articles and 46 met the criteria; most studies focused on sleep apnea.
  2. 2
    Wearable AI was widely used for diagnosing and screening disorders; none of the studies used it for treatment.
  3. 3
    Commercial devices were used in 30 of 46 (65%) studies, with various brands rather than one dominant brand, and 19 (41%) used wrist-worn devices.
  4. 4
    Respiratory data were the main model input in 25 of 46 (54%) studies, followed by heart rate (22/46, 48%) and body movement (17/46, 37%). Convolutional neural networks were used in 17 of 46 (37%), random forests in 14 (30%) and support vector machines in 12 (26%).

Límites e incertidumbre

  1. 1
    A scoping review describes what has been studied and does not statistically combine results, so performance and efficacy are not summarized; the authors say further reviews are needed for that.
  2. 2
    Research on wearables for sleep disorders other than sleep apnea remains limited, so conclusions for insomnia or other conditions are thin.
  3. 3
    Studies used varied commercial brands, so findings cannot be tied to a specific device.
  4. 4
    The authors call for validation of machine learning using clinical data from wearables, and this reading is based on the abstract only.

Relevancia práctica

Wearable AI is being studied as a way to screen for sleep problems, especially sleep apnea, but this review does not show that any consumer device can diagnose them. A wearable alert is a reason to talk to a clinician, not a diagnosis. Treatment decisions belong with a healthcare professional.

Tus datos

Overnight heart rate, breathing-related measures such as respiratory rate or blood oxygen, and movement are the signals these models draw on, and you can see similar data on many devices. Watch your own trends from one device over weeks, and bring persistent patterns or symptoms like loud snoring or daytime sleepiness to a clinician.

Cómo interpretar la evidencia

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Worldwide, 30%-45% of adults have sleep disorders, which are linked to major health issues such as diabetes and cardiovascular disease. Long-term monitoring with traditional in-lab testing is impractical due to high costs. Wearable artificial intelligence (AI)-powered solutions offer accessible, scalable, and continuous monitoring, improving the identification and treatment of sleep problems.

Objective

This scoping review aims to provide an overview of AI-powered wearable devices used for sleep disorders, focusing on study characteristics, wearable technology features, and AI methodologies for detection and analysis.

Methods

Seven electronic databases (MEDLINE, PsycINFO, Embase, IEEE Xplore, ACM Digital Library, Google Scholar, and Scopus) were searched for peer-reviewed literature published before March 2024. Keywords were selected based on 3 domains: sleep disorders, AI, and wearable devices. The primary selection criterion was the inclusion of studies that utilized AI algorithms to detect or predict various sleep disorders using data from wearable devices. Study selection was conducted in 2 steps: first, by reviewing titles and abstracts, followed by full-text screening. Two reviewers independently conducted study selection and data extraction, resolving discrepancies by consensus. The extracted data were synthesized using a narrative approach.

Results

The initial search yielded 615 articles, of which 46 met the eligibility criteria and were included in the final analysis. The majority of studies focused on sleep apnea. Wearable AI was widely deployed for diagnosing and screening disorders; however, none of the studies used it for treatment. Commercial devices were the most commonly used type of wearable technology, appearing in 30 out of 46 (65%) studies. Among these, various brands were utilized rather than a single large, well-known brand; 19 (41%) studies used wrist-worn devices. Respiratory data were used by 25 of 46 (54%) studies as the primary data for model development, followed by heart rate (22/46, 48%) and body movement (17/46, 37%). The most popular algorithm was the convolutional neural network, adopted by 17 of 46 (37%) studies, followed by random forest (14/46, 30%) and support vector machines (12/46, 26%).

Conclusions

Wearable AI technology offers promising solutions for sleep disorders. These devices can be used for screening and diagnosis; however, research on wearable technology for sleep disorders other than sleep apnea remains limited. To statistically synthesize performance and efficacy results, more reviews are needed. Technology companies should prioritize advancements such as deep learning algorithms and invest in wearable AI for treating sleep disorders, given its potential. Further research is necessary to validate machine learning techniques using clinical data from wearable devices and to develop useful analytics for data collection, monitoring, prediction, classification, and recommendation in the context of sleep disorders.

Fuentes y atribución

Wearable Artificial Intelligence for Sleep Disorders: Scoping Review.

Aziz S, A M Ali A, Aslam H, A Abd-Alrazaq A, AlSaad R, Alajlani M, Ahmad R, Khalil L, Ahmed A, Sheikh J.

Journal of medical Internet research · 2025-05-06

DOI: 10.2196/65272 ↗PubMed · 40327852 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Estudio de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explicaciones detalladasLeer estudio →
·Revisión de revisiones

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explicaciones detalladasLeer estudio →
Dispositivos y medición →